Inquiry Basket
Catalog | Product Name | CAS Number |
---|---|---|
BADC-00527 | 2,5-Dioxopyrrolidin-1-yl 3-(4-Methoxyphenoxy)propanoate | 1199815-10-5 |
2, 5-Dioxopyrrolidin-1-yl 3-(4-methoxyphenoxy)propanoate is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
BADC-00528 | 2,5-Dioxopyrrolidin-1-yl 4-((2-((2-(2-(4-(2,6-Dioxo-1,3-Dipropyl-2,3,6,9-Tetrahydro-1H-Purin-8-Yl)phenoxy)acetamido)ethyl)amino)ethyl)disulfanyl)-4-Oxobutanoate | 1222787-24-7 |
2, 5-Dioxopyrrolidin-1-yl 4-((2-((2-(2-(4-(2, 6-dioxo-1, 3-dipropyl-2, 3, 6, 9-tetrahydro-1H-purin-8-yl)phenoxy)acetamido)ethyl)amino)ethyl)disulfanyl)-4-oxobutanoate is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
BADC-00529 | 4-Formyl-N-(2-Phenoxyethyl)benzamide | 1225575-00-7 |
4-Formyl-N-(2-phenoxyethyl)benzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
BADC-00530 | 4-Formyl-N-(2-(m-Tolyloxy)ethyl)benzamide | 1225587-15-4 |
4-Formyl-N-(2-(m-tolyloxy)ethyl)benzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
BADC-00531 | N-(2-(4-Fluorophenoxy)ethyl)-4-Formylbenzamide | 1225588-22-6 |
N-(2-(4-Fluorophenoxy)ethyl)-4-formylbenzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
BADC-00532 | N-(2-(3-Fluorophenoxy)ethyl)-4-Formylbenzamide | 1225588-29-3 |
N-(2-(3-Fluorophenoxy)ethyl)-4-formylbenzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
BADC-00533 | N-(2-(2-Fluorophenoxy)ethyl)-4-Formylbenzamide | 1225705-45-2 |
N-(2-(2-Fluorophenoxy)ethyl)-4-formylbenzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
BADC-00534 | N-(2-(3-Ethylphenoxy)ethyl)-4-Formylbenzamide | 1225790-49-7 |
N-(2-(3-Ethylphenoxy)ethyl)-4-formylbenzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
BADC-00535 | N-(2-(4-Ethylphenoxy)ethyl)-4-Formylbenzamide | 1225790-59-9 |
N-(2-(4-Ethylphenoxy)ethyl)-4-formylbenzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
BADC-00536 | N-(2-(2,6-Dimethylphenoxy)ethyl)-4-Formylbenzamide | 1225936-91-3 |
N-(2-(2, 6-Dimethylphenoxy)ethyl)-4-formylbenzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
BADC-00537 | 4-Formyl-N-(2-(2-Isopropylphenoxy)ethyl)benzamide | 1225964-49-7 |
4-Formyl-N-(2-(2-isopropylphenoxy)ethyl)benzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
BADC-00538 | 4-Formyl-N-(2-(2,4,5-Trimethylphenoxy)ethyl)benzamide | 1225964-74-8 |
4-Formyl-N-(2-(2, 4, 5-trimethylphenoxy)ethyl)benzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
BADC-00539 | N-(2-(2-Chlorophenoxy)ethyl)-4-Formylbenzamide | 1225972-65-5 |
N-(2-(2-Chlorophenoxy)ethyl)-4-formylbenzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
BADC-00540 | N-(2-((2,3-Dihydro-1H-Inden-5-yl)oxy)ethyl)-4-Formylbenzamide | 1225979-81-6 |
N-(2-((2, 3-Dihydro-1H-inden-5-yl)oxy)ethyl)-4-formylbenzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
BADC-00541 | N-(2-(Benzo[d][1,3]dioxol-5-yloxy)ethyl)-4-Formylbenzamide | 1226006-03-6 |
N-(2-(Benzo[d][1, 3]dioxol-5-yloxy)ethyl)-4-formylbenzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
BADC-00542 | 4-Formyl-N-(2-(2-Methoxy-4-Methylphenoxy)ethyl)benzamide | 1226006-54-7 |
4-Formyl-N-(2-(2-methoxy-4-methylphenoxy)ethyl)benzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
BADC-00543 | N-(2-(3-Ethoxyphenoxy)ethyl)-4-Formylbenzamide | 1226006-55-8 |
N-(2-(3-Ethoxyphenoxy)ethyl)-4-formylbenzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
BADC-00544 | 4-Formyl-N-(2-(4-Methoxyphenoxy)ethyl)benzamide | 1226012-11-8 |
4-Formyl-N-(2-(4-methoxyphenoxy)ethyl)benzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
BADC-00545 | N-(2-(3-(Dimethylamino)phenoxy)ethyl)-4-Formylbenzamide | 1226019-77-7 |
N-(2-(3-(Dimethylamino)phenoxy)ethyl)-4-formylbenzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
BADC-00546 | N-(2-(4-Chlorophenoxy)ethyl)-4-Formylbenzamide | 1226050-10-7 |
N-(2-(4-Chlorophenoxy)ethyl)-4-formylbenzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry |